RNF222
gene geneOn this page
Summary
RNF222 (ring finger protein 222, HGNC:34517) is a protein-coding gene on chromosome 17p13.1, encoding RING finger protein 222 (A6NCQ9).
Predicted to enable zinc ion binding activity. Predicted to be located in membrane.
Source: NCBI Gene 643904 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 52 total
- MANE Select transcript:
NM_001146684
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34517 |
| Approved symbol | RNF222 |
| Name | ring finger protein 222 |
| Location | 17p13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000189051 |
| Ensembl biotype | protein_coding |
| Entrez | 643904 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000344001, ENST00000399398
RefSeq mRNA: 1 — MANE Select: NM_001146684
NM_001146684
CCDS: CCDS45608
Canonical transcript exons
ENST00000399398 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001537967 | 8390702 | 8393486 |
| ENSE00001537968 | 8394178 | 8394329 |
| ENSE00001537969 | 8397695 | 8397827 |
Expression profiles
Bgee: expression breadth broad, 29 present calls, max score 92.60.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0414 / max 6.9722, expressed in 15 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 164432 | 0.0414 | 15 |
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 92.60 | gold quality |
| esophagus mucosa | UBERON:0002469 | 78.83 | gold quality |
| skin of leg | UBERON:0001511 | 72.78 | gold quality |
| zone of skin | UBERON:0000014 | 72.25 | gold quality |
| skin of abdomen | UBERON:0001416 | 71.72 | gold quality |
| vagina | UBERON:0000996 | 60.69 | gold quality |
| esophagus | UBERON:0001043 | 57.08 | gold quality |
| tonsil | UBERON:0002372 | 55.33 | gold quality |
| placenta | UBERON:0001987 | 52.60 | gold quality |
| bone marrow | UBERON:0002371 | 52.37 | gold quality |
| bone marrow cell | CL:0002092 | 49.73 | gold quality |
| ectocervix | UBERON:0012249 | 47.09 | gold quality |
| uterine cervix | UBERON:0000002 | 46.67 | gold quality |
| blood | UBERON:0000178 | 46.44 | silver quality |
| granulocyte | CL:0000094 | 42.94 | silver quality |
| minor salivary gland | UBERON:0001830 | 42.91 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 42.30 | gold quality |
| endometrium | UBERON:0001295 | 42.25 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 42.24 | gold quality |
| sural nerve | UBERON:0015488 | 42.10 | gold quality |
| colonic epithelium | UBERON:0000397 | 42.04 | gold quality |
| lymph node | UBERON:0000029 | 41.19 | gold quality |
| cortical plate | UBERON:0005343 | 39.79 | gold quality |
| ganglionic eminence | UBERON:0004023 | 38.83 | gold quality |
| vermiform appendix | UBERON:0001154 | 38.73 | silver quality |
| muscle tissue | UBERON:0002385 | 38.71 | gold quality |
| multicellular organism | UBERON:0000468 | 37.85 | gold quality |
| urinary bladder | UBERON:0001255 | 36.68 | gold quality |
| liver | UBERON:0002107 | 36.58 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.43 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rnf222 | ENSMUSG00000046490 |
| rattus_norvegicus | Rnf222 | ENSRNOG00000022964 |
Protein
Protein identifiers
RING finger protein 222 — A6NCQ9 (reviewed: A6NCQ9)
All UniProt accessions (1): A6NCQ9
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (1): NP_001140156* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001841 | Znf_RING | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR017907 | Znf_RING_CS | Conserved_site |
| IPR027370 | Znf-RING_euk | Domain |
| IPR042973 | RNF222 | Family |
Pfam: PF13445
UniProt features (5 total): chain 1, transmembrane region 1, zinc finger region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NCQ9-F1 | 63.13 | 0.10 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 40 (showing top):
ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GSE13522_WT_VS_IFNG_KO_SKIN_UP, SKP2_TARGET_GENES, MIR4728_5P, MIR6785_5P, MIR182_5P, MIR149_3P, MIR6883_5P, MIR3182, MIR6887_3P, MIR4653_5P, MIR3921, MIR337_3P, MIR4667_3P, MIR1301_3P_MIR5047
GO Biological Process (0):
GO Molecular Function (2): zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transition metal ion binding | 1 |
| cation binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
154 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RNF222 | SEZ6L | Q9BYH1 | 574 |
| RNF222 | TMEM220 | Q6QAJ8 | 526 |
| RNF222 | ZZEF1 | O43149 | 477 |
| RNF222 | SAMD1 | Q6SPF0 | 471 |
| RNF222 | PI15 | O43692 | 455 |
| RNF222 | CUZD1 | Q86UP6 | 432 |
| RNF222 | MUC15 | Q8N387 | 425 |
| RNF222 | GABRP | O00591 | 414 |
| RNF222 | GABRD | O14764 | 399 |
| RNF222 | NUP210 | Q8TEM1 | 398 |
| RNF222 | OLFML2B | Q68BL8 | 394 |
| RNF222 | DMGDH | Q9UI17 | 365 |
| RNF222 | BACE2 | Q9Y5Z0 | 356 |
| RNF222 | ANP32E | Q9BTT0 | 325 |
| RNF222 | RMI2 | Q96E14 | 318 |
IntAct
0 interactions, top by confidence:
BioGRID (1): RNF222 (Affinity Capture-MS)
ESM2 similar proteins: A6NCL7, A6NCQ9, A6QP29, A6QQV9, B1AVH7, B5DFA1, D2H0G5, D2H6Z0, D2H788, D3ZBM4, D4A723, E1C2W7, O95153, Q0QWG9, Q3SWY0, Q3T0Y9, Q3U0L2, Q3UV31, Q3V3A7, Q5RF77, Q60943, Q6INB3, Q6PGG2, Q7TNF8, Q7Z465, Q80TI1, Q810L3, Q8BG47, Q8BRJ3, Q8BXP5, Q8C0R7, Q8C432, Q8CEF8, Q8HYZ0, Q8N0U2, Q8N6D2, Q8N8N0, Q8NC24, Q8QZS5, Q8TED9
Diamond homologs: A6NCQ9, E7ERA6, M0QZC1, Q3UV31, Q6ZWI9, Q8CEF8, Q9D7D1, P0DH78, Q13049, Q3SWY0, Q3UIW8, Q8CH72, Q8QZS5, Q96D59, E1BD59, O16616, Q5ZMD4, Q6VVB1, Q8IWR1, Q922Y2, Q9BRZ2, Q9D241, Q5E9G4, Q5M929
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | RNF222 | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 49 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
48 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:8392810:T:TA | donor_gain | 0.9300 |
| 17:8392801:ACG:A | donor_gain | 0.8100 |
| 17:8392802:CGC:C | donor_gain | 0.8100 |
| 17:8392785:C:CA | donor_gain | 0.7900 |
| 17:8392811:C:A | donor_gain | 0.6300 |
| 17:8392810:TCCTC:T | donor_gain | 0.5700 |
| 17:8393332:TG:T | donor_gain | 0.5500 |
| 17:8392818:A:T | donor_gain | 0.4700 |
| 17:8392814:C:T | donor_gain | 0.4300 |
| 17:8392784:T:TA | donor_gain | 0.4100 |
| 17:8392802:CG:C | donor_gain | 0.3800 |
| 17:8393026:C:CA | donor_gain | 0.3200 |
| 17:8392482:C:A | acceptor_gain | 0.3100 |
| 17:8392545:AGC:A | acceptor_loss | 0.3000 |
| 17:8392546:GCCT:G | acceptor_loss | 0.3000 |
| 17:8392547:CC:C | acceptor_loss | 0.3000 |
| 17:8392548:C:A | acceptor_loss | 0.3000 |
| 17:8392548:C:CC | acceptor_gain | 0.3000 |
| 17:8392549:T:A | acceptor_loss | 0.3000 |
| 17:8392803:G:C | donor_gain | 0.3000 |
| 17:8392550:A:C | acceptor_loss | 0.2900 |
| 17:8392852:C:CT | donor_gain | 0.2800 |
| 17:8392542:C:CT | acceptor_gain | 0.2700 |
| 17:8392543:C:CG | acceptor_gain | 0.2700 |
| 17:8392546:G:GA | acceptor_gain | 0.2500 |
| 17:8392256:C:A | acceptor_gain | 0.2400 |
| 17:8392817:C:CT | donor_gain | 0.2300 |
| 17:8391333:T:G | acceptor_gain | 0.2200 |
| 17:8392137:CCCCT:C | acceptor_gain | 0.2200 |
| 17:8392541:TCC:T | acceptor_gain | 0.2200 |
AlphaMissense
1395 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:8393281:A:G | C61R | 1.000 |
| 17:8393351:G:C | F37L | 1.000 |
| 17:8393351:G:T | F37L | 1.000 |
| 17:8393352:A:G | F37S | 1.000 |
| 17:8393353:A:G | F37L | 1.000 |
| 17:8393422:A:G | C14R | 1.000 |
| 17:8393270:G:C | C64W | 0.999 |
| 17:8393271:C:A | C64F | 0.999 |
| 17:8393271:C:G | C64S | 0.999 |
| 17:8393271:C:T | C64Y | 0.999 |
| 17:8393272:A:G | C64R | 0.999 |
| 17:8393272:A:T | C64S | 0.999 |
| 17:8393279:G:C | C61W | 0.999 |
| 17:8393280:C:G | C61S | 0.999 |
| 17:8393280:C:T | C61Y | 0.999 |
| 17:8393281:A:T | C61S | 0.999 |
| 17:8393339:G:C | C41W | 0.999 |
| 17:8393340:C:G | C41S | 0.999 |
| 17:8393340:C:T | C41Y | 0.999 |
| 17:8393341:A:G | C41R | 0.999 |
| 17:8393341:A:T | C41S | 0.999 |
| 17:8393348:G:C | C38W | 0.999 |
| 17:8393349:C:T | C38Y | 0.999 |
| 17:8393350:A:G | C38R | 0.999 |
| 17:8393352:A:C | F37C | 0.999 |
| 17:8393363:A:C | C33W | 0.999 |
| 17:8393364:C:G | C33S | 0.999 |
| 17:8393364:C:T | C33Y | 0.999 |
| 17:8393365:A:G | C33R | 0.999 |
| 17:8393365:A:T | C33S | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000030344 (17:8391824 C>T), RS1000144632 (17:8391662 T>G), RS1000344784 (17:8397706 G>C), RS1000884238 (17:8394405 A>C), RS1001824361 (17:8391955 T>C,G), RS1002281783 (17:8398908 A>G), RS1002373338 (17:8393282 G>A), RS1002573977 (17:8398658 C>A,T), RS1002668639 (17:8397409 A>C), RS1002966863 (17:8391579 C>A,G,T), RS1003122392 (17:8396020 A>G), RS1003379897 (17:8394699 C>T), RS1003417716 (17:8395757 G>T), RS1003893042 (17:8398565 C>T), RS1004837665 (17:8391555 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation, increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.